Viridian Therapeutics's total assets for Q1 2025 were $660.98M, a decrease of -10.97% from the previous quarter. VRDN total liabilities were $56.51M for the fiscal quarter, a -20.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.